Bharat Biotech’s nasal vaccine enters 2nd phase of human trials in Kanpur today
The second phase of human trials for the intra-nasal COVID vaccine, BBV 154, has started in Kanpur from today onwards. ...
The second phase of human trials for the intra-nasal COVID vaccine, BBV 154, has started in Kanpur from today onwards. ...